Hematopoietic cell transplantation in first complete remission versus early relapse

This publication has 11 references indexed in Scilit:

• Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
  New England Journal of Medicine, 2004
• Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
  Blood, 2003
• Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
  Blood, 2002
• Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
  Blood, 2000
• Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
  New England Journal of Medicine, 1998
• Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial
  The Lancet, 1998
• High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group
  Blood, 1995
• Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia
  New England Journal of Medicine, 1995
• Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
  Journal of Clinical Oncology, 1992
• Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse
  Blood, 1983